Benjamin Dannenmann
Impact in
-
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
Papers in
- Genetics 11
- Blood disorders and treatments 11
-
- CRISPR and Genetic Engineering 6
- Pluripotent Stem Cells Research 4
- Co-authors
- Klaus Schulze‐Osthoff (7 shared papers)Julia Skokowa (17 shared papers)Frank Eßmann (3 shared papers)Simon Lehle (3 shared papers)Oliver C. Rothfuss (2 shared papers)Karl Welte (14 shared papers)Katharina Holzer (1 shared paper)Dominic G. Hildebrand (1 shared paper)
In The Last Decade
Benjamin Dannenmann
20 papers receiving 249 citations
Peers
Comparison fields: 5 of 74
- Hematology 32
- Business and International Management 5
- Molecular Biology 131
- Immunology 36
- Aging 3
Countries citing papers authored by Benjamin Dannenmann
This map shows the geographic impact of Benjamin Dannenmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Dannenmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Dannenmann more than expected).
Fields of papers citing papers by Benjamin Dannenmann
This network shows the impact of papers produced by Benjamin Dannenmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Dannenmann. The network helps show where Benjamin Dannenmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Dannenmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 73 | |
| 2 | 2020 | 37 | |
| 3 | 2015 | 19 | |
| 4 | 2017 | 18 | |
| 5 | 2019 | 16 | |
| 6 | 2018 | 15 | |
| 7 | 2019 | 14 | |
| 8 | 2021 | 13 | |
| 9 | 2024 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2025 | 7 | |
| 12 | 2015 | 7 | |
| 13 | 2019 | 3 | |
| 14 | 2024 | 3 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2018 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2020 | 1 |
About Benjamin Dannenmann
Benjamin Dannenmann is a scholar working on Genetics, Molecular Biology, Oncology, Hematology and Physiology, having authored 22 papers that have together received 251 indexed citations. Recurring topics across this work include Blood disorders and treatments (11 papers), Neutropenia and Cancer Infections (8 papers), CRISPR and Genetic Engineering (6 papers), Acute Myeloid Leukemia Research (5 papers), Pluripotent Stem Cells Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Erythrocyte Function and Pathophysiology (3 papers) and Cytomegalovirus and herpesvirus research (2 papers). The work is most often cited by research in Hematology (32 citations), Business and International Management (5 citations), Molecular Biology (131 citations), Immunology (36 citations) and Aging (3 citations). Benjamin Dannenmann has collaborated with scholars based in Germany, Austria and Japan. Frequent co-authors include Klaus Schulze‐Osthoff, Julia Skokowa, Frank Eßmann, Simon Lehle, Oliver C. Rothfuss, Karl Welte, Katharina Holzer, Dominic G. Hildebrand, Yun Xu and Maksim Klimiankou. Their work appears in journals such as Blood, Molecular Therapy, Blood Advances, Experimental Hematology and Stem Cell Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.